Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection

scientific article published on 29 March 2012

Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2215/CJN.12531211
P698PubMed publication ID22461534

P2093author name stringDavid J Taber
Prabhakar Baliga
Jill C Krisl
John McGillicuddy
Beje Thomas
Kenneth Chavin
Nicole Pilch
Charles Bratton
P433issue6
P921main subjectpharmacodynamicsQ725307
P304page(s)1003-1009
P577publication date2012-03-29
P1433published inClinical Journal of the American Society of NephrologyQ15757929
P1476titleLeflunomide efficacy and pharmacodynamics for the treatment of BK viral infection
P478volume7

Reverse relations

cites work (P2860)
Q3880139445 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches
Q104472864Advances in BK Virus Complications in Organ Transplantation and Beyond
Q41907468Antiviral effects of artesunate on polyomavirus BK replication in primary human kidney cells
Q45323585Antiviral treatment of BK virus viremia after kidney transplantation
Q39180715BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.
Q39155699Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature
Q47159198Inhibition of Retrograde Transport Limits Polyomavirus Infection In Vivo
Q92314978Leflunomide for BKvirus: Report of Seven Kidney-Transplanted Children
Q96950587Leflunomide in the treatment of BK polyomavirus associated nephropathy in kidney transplanted patients - A systematic review
Q38269958Observations on the use of cidofovir for BK virus infection in renal transplantation
Q40963564Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction
Q38940498Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe
Q40329754Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy
Q39983951The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot Study.
Q28292658The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation
Q42420884Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn?
Q91229914Viremia Negativization After BK Virus Infection in Kidney Transplantation: A National Bicentric Study

Search more.